Westminster Pharmaceuticals LLC is recalling 21,128 bottles of Metoprolol Tartrate Tablets, USP (50 mg and 100 mg strengths) due to the presence of N-nitroso-metoprolol. This chemical is a type of nitrosamine that was found at levels higher than the established Acceptable Daily Intake limit. The affected products include 16,672 bottles of the 50 mg strength and 4,456 bottles of the 100 mg strength, all packaged in 1000-count bottles for prescription use. Consumers should speak with their doctor or pharmacist about alternative treatment options before stopping their medication.
N-nitroso-metoprolol is a nitrosamine compound, which is classified as a potential human carcinogen. Long-term exposure to these impurities above acceptable levels may increase the risk of cancer.
You have 2 options:
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.